| abstract |
Described herein are quinoline-based inhibitors of cyclin dependent kinase 2, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions containing them are useful for treating diseases or disease symptoms. The present invention also provides methods for making CDK-2 inhibitor compounds, methods for inhibiting CDK-2, and methods for treating diseases or disease symptoms. |